115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase III randomized trial on surgery, chemo and pleural radiation (IMPRINT) for resectable pleural mesothelioma (NRG LU-006)
    Meeting Abstract

    Rimner, A.; Hu, C.; Simone, C. B. 2nd; Rusch, V. W.; Zauderer, M. G.; Gill, R. R.; Yorke, E. D.; Li, Z.; Voong, K. R.; Peikert, T.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • A deep learning auto-segmentation tool for cardiac substructures in 4D radiotherapy planning for locally advanced lung cancer
    Meeting Abstract

    Walls, G. M.; Giacometti, V.; Apte, A.; Thor, M.; McCann, C.; Hanna, G. G.; O'Connor, J.; Deasy, J. O.; Hounsell, A. R.; Butterworth, K. T.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Mutations in CREBBP are associated with local failure after lung stereotactic body radiation therapy
    Meeting Abstract

    Ng, V.; Rimner, A.; Sidiqi, B.; Lebow, E. S.; Shaverdian, N.; Gelblum, D. Y.; Shepherd, A. F.; Simone, C. B. 2nd; Gomez, D. R.; Wu, A. J.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • The Campaign to End Lung Cancer Stigma: The ACS National Lung Cancer Roundtable efforts to confront and extinguish lung cancer stigma
    Meeting Abstract

    Studts, J.; Carter, L.; Feldman, J.; Donaldson, D.; Pantelas, J.; Ostroff, J.; Stiles, B.; Scharnetzki, E.; Smith, R.; Kazernooni, E.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Adaptation of empathic communication skills training for oncology care providers to reduce lung cancer stigma
    Meeting Abstract

    Ostroff, J.; Banerjee, S.; Malling, C.; Parker, P.; Carter-Harris, L.; Emard, N.; Shen, M.; Williamson, T.; Hamann, H.; Bylund, C.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Genomic mapping of metastatic organotropism: Analysis of 2326 primary and organ-specific metastases in lung adenocarcinoma
    Meeting Abstract

    Lengel, H.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Entrectinib in patients with ROS1 fusion-positive (ROS1-fp) NSCLC: Updated efficacy and safety analysis
    Meeting Abstract

    Fan, Y.; Drilon, A.; Chiu, C. H.; Bowles, D. W.; Loong, H. H. F.; Siena, S.; Goto, K.; Krzakowski, M.; Ahn, M. J.; Murakami, H.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1 trial of sapanisertib and telaglenastat (CB-839) in patients with advanced NSCLC (NCI 10327): Results from dose escalation
    Meeting Abstract

    Riess, J.; Frankel, P.; Massarelli, E.; Nieva, J.; Lai, W. C. V.; Koczywas, M.; Shackelford, D.; Lanza, I.; Reid, J. M.; Gonsalves, W. I.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • TA0953/HM06, a novel RET-specific inhibitor effective in extracranial and CNS disease models of NSCLC with RETfusions
    Meeting Abstract

    Odintsov, I.; Lui, A. J. W.; Delasos, L.; Khodos, I.; Chang, Q.; Mattar, M. S.; Vojnic, M.; Lu, Y. C.; Kunte, S.; Bonifacio, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Defining morphologic features of invasion in pulmonarynon-mucinousadenocarcinoma with lepidic growth
    Meeting Abstract

    Thunnissen, E; Borczuk, A.; Beasly, M. B.; Tsao, M.; Kerr, K.; Dacic, S.; Minami, Y.; Nicholson, A.; Lissenberg-Witte, B.; Roden, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save